ES2062754T3 - Eliminacion de linfocitos activados. - Google Patents

Eliminacion de linfocitos activados.

Info

Publication number
ES2062754T3
ES2062754T3 ES91900757T ES91900757T ES2062754T3 ES 2062754 T3 ES2062754 T3 ES 2062754T3 ES 91900757 T ES91900757 T ES 91900757T ES 91900757 T ES91900757 T ES 91900757T ES 2062754 T3 ES2062754 T3 ES 2062754T3
Authority
ES
Spain
Prior art keywords
elimination
activated lymphocytes
activated
lymphocytes
octadecylglycero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91900757T
Other languages
English (en)
Inventor
Eberhard Wecker
Anneliese Schimpl
Rabbe Nordstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedMark Pharma GmbH
Original Assignee
MedMark Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedMark Pharma GmbH filed Critical MedMark Pharma GmbH
Application granted granted Critical
Publication of ES2062754T3 publication Critical patent/ES2062754T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ELIMINACION DE LINFOCITOS ACTIVADOS. LA 2 IGENOS O MITOGENOS EN MAMIFEROS.
ES91900757T 1989-12-12 1990-12-11 Eliminacion de linfocitos activados. Expired - Lifetime ES2062754T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3941009A DE3941009A1 (de) 1989-12-12 1989-12-12 Eliminierung von aktivierten lymphozyten

Publications (1)

Publication Number Publication Date
ES2062754T3 true ES2062754T3 (es) 1994-12-16

Family

ID=6395316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91900757T Expired - Lifetime ES2062754T3 (es) 1989-12-12 1990-12-11 Eliminacion de linfocitos activados.

Country Status (13)

Country Link
EP (1) EP0505414B1 (es)
JP (1) JPH05504132A (es)
AT (1) ATE102038T1 (es)
AU (1) AU638086B2 (es)
CA (1) CA2071520C (es)
DE (2) DE3941009A1 (es)
DK (1) DK0505414T3 (es)
ES (1) ES2062754T3 (es)
FI (1) FI922710A0 (es)
HU (1) HU217586B (es)
NO (1) NO922304D0 (es)
RU (1) RU2100025C1 (es)
WO (1) WO1991008746A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5517234A (en) * 1993-10-26 1996-05-14 Gerber Systems Corporation Automatic optical inspection system having a weighted transition database
DE19822509A1 (de) * 1998-05-19 1999-11-25 Medmark Pharma Gmbh Edelfosin zur Behandlung von Hirntumoren
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
EP1981488A1 (en) * 2005-12-23 2008-10-22 Jado Technologies GmbH Means and methods for the treatment and prevention of allergic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen

Also Published As

Publication number Publication date
JPH05504132A (ja) 1993-07-01
RU2100025C1 (ru) 1997-12-27
ATE102038T1 (de) 1994-03-15
AU6954391A (en) 1991-07-18
AU638086B2 (en) 1993-06-17
DK0505414T3 (da) 1994-05-09
EP0505414A1 (de) 1992-09-30
EP0505414B1 (de) 1994-03-02
NO922304L (no) 1992-06-11
FI922710A0 (fi) 1992-06-11
DE3941009A1 (de) 1991-06-13
CA2071520A1 (en) 1991-06-13
HU9201976D0 (en) 1992-09-28
DE59004836D1 (de) 1994-04-07
WO1991008746A1 (de) 1991-06-27
NO922304D0 (no) 1992-06-11
HUT60927A (en) 1992-11-30
CA2071520C (en) 2002-10-01
HU217586B (hu) 2000-02-28

Similar Documents

Publication Publication Date Title
EP0261224A4 (en) SYNTHETIC HTLV III PEPTIDE COMPOSITIONS AND THEIR USE.
IT1100477B (it) Procedimento e mezzo per l'espressione microbica di polipertidi
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
DK0435321T3 (da) Nye A-nor-steroid-3-carboxylsyrederivater
ES526896A0 (es) Procedimiento para la preparacion de b-carbolinas
DE68929060T2 (de) Synthese von 1,2-Dioxetanen und Zwischenprodukte dafür
FR2392959A1 (fr) Amino-acides et procede d'obtention
ES2062754T3 (es) Eliminacion de linfocitos activados.
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
AP8800109A0 (en) "Heterocyclic insecticides".
FI860426A (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
FR2454436A1 (fr) Polypeptide synthetique a activite antigenique et procede pour sa preparation
ES8502092A1 (es) Un procedimiento de resolucion de trans-d1-1-n-propil-6-oxodecahidroquinolina en sus isomeros opticos
IT1239470B (it) Procedimento e dispositivo per la fabbricazione di contenitori ricoperti mediante fogli di copertura
AU548094B2 (en) Unsaturated halogenated diamines
DE3376650D1 (en) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenyl isoquinolines and methods of preparation
FR2659651B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphenylene diamines.
FR2659650B1 (fr) Procede de preparation de n-phenyl n'-(cyclo)alkyl paraphnylene diamines.
MY104318A (en) Novel thiopen compounds and their preparation
ATA109689A (de) Brennerplatte eines atmosphaerischen brenners
FR2645445B1 (fr) Technique d'elimination du pyralene et de melanges pyralene-huiles par voie biologique
SU1417444A1 (ru) 2,4-Дифенил-3(4-ацетокси-4-метилгексин-2-ил)-3-азабицикло [3,3,1]нонан-9-он, проявляющий противовоспалительную активность
RO93262A2 (ro) Mediu de cultura pentru identificarea vibrionilor
IT8921302A0 (it) Composizione conservabile per l'alimentazione di giovani mammiferi e procedimento per la sua preparazione.
SU1269465A1 (ru) Способ получения 2-анилино-7-гидрокси-6н-1,3,4-тиадиазепинов

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 505414

Country of ref document: ES